DUSA Pharmaceuticals Inc., a prominent player in the dermatology sector, is headquartered in the United States. Founded in 1991, the company has established itself as a leader in developing innovative therapies for skin conditions, particularly in the treatment of actinic keratosis and acne. DUSA's flagship product, Levulan® Kerastick®, is renowned for its unique photodynamic therapy approach, setting it apart in the competitive dermatological landscape. With a strong focus on research and development, DUSA Pharmaceuticals has achieved significant milestones, including expanding its product portfolio and enhancing patient access to effective treatments. The company’s commitment to quality and innovation has solidified its market position, making it a trusted name among healthcare professionals and patients alike.
We don't have data for DUSA Pharmaceuticals Inc., but we can show you information about their parent organization instead.
View parent company